Company / Operating Margin
Dare Bioscience, Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-239692.2%
FY2025
5-year range
-239692.2% / -313.9%
FY2023-FY2025
Trend
-21652.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -21653% YoY in FY2025, a notable deviation from the 2-year average annual change of -10952%.
Based on SEC 10-K filings.
-239692.2% in FY2025.
Declined from -313.9% to -239692.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 21652.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -239692.2% | -21652.8% |
| FY2024 | -1101.9% | -251.1% |
| FY2023 | -313.9% | - |
| FY2022 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026